‘Pharmaceuticals giant GlaxoSmithKline posted a 13-percent jump in annual pre-tax profits and said it should start clinical trials within weeks of a vaccine against bird flu.

GSK said 2005 pre-tax profits rose to 6.732 billion pounds (9.805 billion euros, 11.724 billion dollars), while revenue increased 7.0 percent to 21.66 billion pounds from the previous year.’

Read more at GlaxoSmithKline readies bird flu vaccine after annual profits rise

Recent Entries

• Sigma Pharmaceuticals year profit rises 27 pct
• South African citizens cheap drug guinea pigs
• Two drugs test victims face a year in coma
• Can drug companies improve their reputation?
• Pfizer Sees 40 Percent Rise in 2006 Net on Cost Cuts
• Pfizer’s Forecast Disappoints
• Pharmaceutical RFID Adoption Stalls
• Inhalable Drug Might Bring Sigh Of Relief To Diabetes Patients
• GlaxoSmithKline unveils best results since merger
• Pfizer Sues Teva, Sandoz Over Zithromax

This entry was posted on Thursday, February 9th, 2006 at 10:21 pm and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.